Comparison results
| Results: Differences General | ✘Isolated pituitary gland syndrome | ✘Autoimmune polyglandular syndrome | |||||||||||||
| Related research | Analogs | Analogs | |||||||||||||
| |||||||||||||||
| Distinctive symptoms | |||||||||||||||
| Register, to see more distinctive signs of diseases and studies | 22% | — | |||||||||||||
| Register, to see more distinctive signs of diseases and studies | — | 46% | |||||||||||||
| isolated pituitary gland syndrome | 21% | — | |||||||||||||
| asia-syndrome | — | 37% | |||||||||||||
| hypopituitarism | 18% | — | |||||||||||||
| schmidt syndrome | — | 29% | |||||||||||||
| polyuria | 17% | — | |||||||||||||
| superficial candidiasis | — | 25% | |||||||||||||
| pituitary gland diseases | 12% | — | |||||||||||||
| hypoparathyroidism | — | 20% | |||||||||||||
| effects of taking hormones | 12% | — | |||||||||||||
| insulin-dependent diabetes mellitus | — | 18% | |||||||||||||
| insufficiency of pituitary function | 12% | — | |||||||||||||
| candidiasis | — | 17% | |||||||||||||
| panhypopituitarianism | 12% | — | |||||||||||||
| type 1 diabetes mellitus | — | 16% | |||||||||||||
| acth deficiency | 11% | — | |||||||||||||
| cortisol deficiency | — | 15% | |||||||||||||
| deficit of stg | 11% | — | |||||||||||||
| diabetic enteropathy | — | 15% | |||||||||||||
| feeling of isolation | 11% | — | |||||||||||||
| sprue | — | 14% | |||||||||||||
| consequence of hormone treatment | 10% | — | |||||||||||||
| intolerant gluten | — | 14% | |||||||||||||
| prolonged urination | 10% | — | |||||||||||||
| vitamin c increased | — | 14% | |||||||||||||
| consequences of injuries | 10% | — | |||||||||||||
| Addison's disease | — | 14% | |||||||||||||
| dwarfism | 10% | — | |||||||||||||
| congenital aplasia of the skin | — | 14% | |||||||||||||
| pituitary tumors | 10% | — | |||||||||||||
| aldosterone deficiency | — | 14% | |||||||||||||
| hyperprolactinemia | 10% | — | |||||||||||||
| myasthenia | — | 14% | |||||||||||||
| volume of thyroid gland is reduced | 9% | — | |||||||||||||
| autoimmune thyroiditis | — | 14% | |||||||||||||
| trauma | 9% | — | |||||||||||||
| thyroiditis | — | 14% | |||||||||||||
| oncology | 9% | — | |||||||||||||
| hormonal disorders | 7% | 20% | |||||||||||||
| leg injury | 8% | — | |||||||||||||
| diabetes mellitus | — | 13% | |||||||||||||
| history of surgery | 8% | — | |||||||||||||
| convulsions | — | 13% | |||||||||||||
| sensations in the legs | 7% | — | |||||||||||||
| insulin deficiency | — | 12% | |||||||||||||
| bacteremia | 7% | — | |||||||||||||
| type 2 diabetes mellitus | — | 12% | |||||||||||||
| sepsis | 7% | — | |||||||||||||
| skin problems | — | 11% | |||||||||||||
| consequences of surgery | 6% | — | |||||||||||||
| increased calcium | — | 11% | |||||||||||||
| onset of illness | 6% | — | |||||||||||||
| consultation of a gastroenterologist | — | 11% | |||||||||||||
| consequences of taking medications | 6% | — | |||||||||||||
| metabolic syndrome | — | 11% | |||||||||||||
| lowered | 6% | — | |||||||||||||
| cramps in the legs | — | 11% | |||||||||||||
| leukocytosis | — | 10% | |||||||||||||
| enteropathy | — | 10% | |||||||||||||
| hematuria | — | 9% | |||||||||||||
| intoxication | — | 9% | |||||||||||||
| increased | — | 8% | |||||||||||||
| not enough time | 7% | 14% | |||||||||||||
| adrenal insufficiency | 9% | 16% | |||||||||||||
| hypothyroidism | 8% | 15% | |||||||||||||
| congenital hypothyroidism | 10% | 14% | |||||||||||||
| hypoaldosteronism | 10% | 13% | |||||||||||||
| hypogonadism | 9% | 12% | |||||||||||||
Instructions
Video 
- Introduce new diseases through 🔍 Search and input on the top panel using
- The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
- The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
- The list changes dynamically depending on the data of the current visit in the selection of therapy .
- Click on the percentageto see the suggestions from the original source.
- By using the service, you agree to user agreement.
